By the same authors

From the same journal

Commerical development of stem cell technology: lessons from the past, strategies for the future

Research output: Contribution to journalLiterature review

Published copy (DOI)

Author(s)

  • Paul A. Martin
  • Catherine Coveney
  • Alison Kraft
  • Nik Brown
  • Philip Bath

Department/unit(s)

Publication details

JournalREGENERATIVE MEDICINE
DatePublished - Nov 2006
Issue number6
Volume1
Number of pages7
Pages (from-to)801-807
Original languageEnglish

Abstract

This paper presents historical and contemporary survey data on the commercial development of stem cell technology from the 1990s to the present day. We describe the first wave of industrial investment in hematopoietic stem cells during the 1990s and contrast this with the more recent expansion of the sector. In particular, we explore the cell types used, diseases targeted and business models adopted by firms. We conclude, by arguing that the commercial prospects for stem cell technologies remain highly uncertain and that innovative public policies should be adopted to prevent 'market failure'.

    Research areas

  • firm strategies, industry, public policy, stem cells

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations